{"title":"Peculiarities of carrying out pre-vaccination diagnostics in Ukraine in order to determine the organism adaptability","authors":"Yuliia Tyravska","doi":"10.57125/fem.2023.03.30.05","DOIUrl":null,"url":null,"abstract":"This article focused on peculiarities of carrying out pre-vaccination diagnostics in Ukraine in order to determine the organism adaptability.\n\nAims: The aims of this study are to investigate the peculiarities of performing pre-vaccination diagnostics in Ukraine to ascertain the adaptability of the organism.\n\nMethodology: A descriptive cross-sectional study design was used. Secondary data was utilised and analysed. Descriptive statistics obtained and utilised\n\nResults: showed that Ukraine has over 4,000 registered microbiological laboratories, but only 2 are allowed to work with microorganisms of the first pathogenic group, 402 with the second, and all others with the third and fourth. The relevant information indicates that there are no BSL-4-compliant laboratories in Ukraine. The barriers and facilitators are such as organisational, logistical, and resource-related challenges, as well as factors that promote or delay the use of diagnostic tests in the vaccination process. In 2021, 88.5% of individuals received the first dose of the measles vaccine, while in 2020 and 2019 the coverage rates were 84.9% and 93.2%, respectively. Similarly, for the second dose of the measles vaccine, the coverage rates were 85.9%, 81.9%, and 91.7% in 2021, 2020, and 2019, respectively. Among the reasons, the desire to protect oneself (63.6%) and to others (12.5%) were the most frequent justifications for vaccination; 12.8% of respondents chose to be vaccinated for employment-related reasons. As the study found among other reasons there was the lack of awareness and knowledge about the importance of pre-vaccination diagnostics among healthcare providers and the general public, a significant barrier to compliance with national and international guidelines.\n\nScientific Novelty: Pre-vaccination diagnostic peculiarities\n\nConclusion: The research findings suggest that there may be peculiarities in the implementation of pre-vaccination diagnostics in Ukraine, with potential challenges related to adherence to established guidelines, stakeholder perspectives, and organisational factors.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"54 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Futurity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.57125/fem.2023.03.30.05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This article focused on peculiarities of carrying out pre-vaccination diagnostics in Ukraine in order to determine the organism adaptability.
Aims: The aims of this study are to investigate the peculiarities of performing pre-vaccination diagnostics in Ukraine to ascertain the adaptability of the organism.
Methodology: A descriptive cross-sectional study design was used. Secondary data was utilised and analysed. Descriptive statistics obtained and utilised
Results: showed that Ukraine has over 4,000 registered microbiological laboratories, but only 2 are allowed to work with microorganisms of the first pathogenic group, 402 with the second, and all others with the third and fourth. The relevant information indicates that there are no BSL-4-compliant laboratories in Ukraine. The barriers and facilitators are such as organisational, logistical, and resource-related challenges, as well as factors that promote or delay the use of diagnostic tests in the vaccination process. In 2021, 88.5% of individuals received the first dose of the measles vaccine, while in 2020 and 2019 the coverage rates were 84.9% and 93.2%, respectively. Similarly, for the second dose of the measles vaccine, the coverage rates were 85.9%, 81.9%, and 91.7% in 2021, 2020, and 2019, respectively. Among the reasons, the desire to protect oneself (63.6%) and to others (12.5%) were the most frequent justifications for vaccination; 12.8% of respondents chose to be vaccinated for employment-related reasons. As the study found among other reasons there was the lack of awareness and knowledge about the importance of pre-vaccination diagnostics among healthcare providers and the general public, a significant barrier to compliance with national and international guidelines.
Scientific Novelty: Pre-vaccination diagnostic peculiarities
Conclusion: The research findings suggest that there may be peculiarities in the implementation of pre-vaccination diagnostics in Ukraine, with potential challenges related to adherence to established guidelines, stakeholder perspectives, and organisational factors.